Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating tuberculosis and preparation method thereof

A composition and technology of pulmonary tuberculosis, applied in the direction of drug combination, pharmaceutical formula, active ingredient of heterocyclic compounds, etc., can solve the problem of not obvious inhibition of dextran arthritis

Inactive Publication Date: 2017-03-22
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has also been reported that horse chestnut bark glucoside also has inhibitory effect on formaldehyde-induced arthritis, but it is weaker than that of dextran-induced arthritis, and the inhibition on dextran-induced arthritis is not obvious.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating tuberculosis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0041] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 5575g of walnut kernels, 1300g of lapis lazuli, 4735g of oysters, 2200g of nutmeg, 900g of fenugreek, 40g of lauric anhydride, 85g of (+)-scopolamine, and 65g of glycine;

[0042] Preparation:

[0043] (1) Take walnut kernels, lapis lazuli, oysters, nutmeg, cinnamon bark, lauric anhydride, (+)-scopolamine, glycine according to the ratio of raw materials, mix well, use ethanol with a concentration of 38% by weight as a solvent, and heat at 38°C Warm immersion extraction, the number of extractions is 8 times, each extraction time is 20 hours, and the amount of solvent used each time is 40 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, c...

Embodiment 2

[0046] Embodiment 2: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0047] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 5525g of walnut kernel, 1350g of kelp, 4685g of oyster, 2250g of nutmeg, 850g of fennel, 45g of lauric anhydride, 80g of (+)-scopolamine, and 70g of glycine;

[0048] Preparation:

[0049] (1) Take walnut kernels, lapis lazuli, oysters, nutmeg, cinnamon bark, lauric anhydride, (+)-scopolamine, glycine according to the ratio of raw materials, mix well, use ethanol with a concentration of 38% by weight as a solvent, and heat at 38°C Warm immersion extraction, the number of extractions is 8 times, each extraction time is 20 hours, and the amount of solvent used each time is 40 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates ...

Embodiment 3

[0052] Embodiment 3: the pharmaceutical composition for the treatment of pulmonary tuberculosis and preparation method thereof

[0053] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating pulmonary tuberculosis are: 5625g of walnut kernels, 1250g of lapis lazuli, 4785g of oysters, 2150g of nutmeg, 950g of fennel, 35g of lauric anhydride, 90g of (+)-scopolamine, and 60g of glycine;

[0054] Preparation:

[0055] (1) Take walnut kernels, lapis lazuli, oysters, nutmeg, cinnamon bark, lauric anhydride, (+)-scopolamine, glycine according to the ratio of raw materials, mix well, use ethanol with a concentration of 38% by weight as a solvent, and heat at 38°C Warm immersion extraction, the number of extractions is 8 times, each extraction time is 20 hours, and the amount of solvent used each time is 40 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, conc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating tuberculosis and a preparation method thereof. The medicine composition is prepared from juglans regia, chlorite schist, oyster, nutmeg, cortex fraxini, lauric anhydride, (+)-scopolamine and glycine serving as raw medical materials in proportions, can be made into various dosage forms according to a conventional preparation technology and has an obvious curative effect on the treatment of the tuberculosis.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a medicinal composition for treating pulmonary tuberculosis and a preparation method thereof. Background technique [0002] Tuberculosis is one of the common infectious diseases. In recent years, the incidence of pulmonary tuberculosis in my country has been increasing year by year, and the trend of rejuvenation is obvious... Clinically, the combined application of conventional bactericidal and bacteriostatic drugs against Mycobacterium tuberculosis has achieved relatively satisfactory therapeutic effects, but with the prolongation of medication time, the problem of drug resistance of Mycobacterium tuberculosis is becoming more and more serious. The development of the drug provides a reliable direction for the treatment of pulmonary tuberculosis, can significantly improve the therapeutic effect, is safe for use, and is worthy of clinical popularization and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/63A61K9/48A61K9/20A61P31/06A61P11/00A61K31/198A61K31/20A61K31/46A61K33/26A61K35/618
CPCA61K9/2031A61K9/2059A61K9/4866A61K31/198A61K31/20A61K31/46A61K33/26A61K35/618A61K36/185A61K36/52A61K36/63A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2236/55A61K2300/00
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com